GlassScriptPhysician profile
Alice Gail Moon
NPI 1790724011
$3,544.43
in general payments reported to CMS, 2019-2025
18 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $434 · 2022: $699 · 2023: $794 · 2024: $566 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,411.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $1,276.70 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Lundbeck LLC | $591.45 | 2021-2025 | Rexulti |
| Abbvie INC. | $447.26 | 2022-2025 | |
| Alkermes, INC. | $352.35 | 2021-2024 | Lybalvi, Aristada |
| Boston Scientific Corporation | $291.55 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Neurocrine Biosciences, INC. | $153.11 | 2024-2025 | Ingrezza |
| Corium, LLC | $100.89 | 2022-2024 | Azstarys |
| Teva Pharmaceuticals USA, INC. | $92.83 | 2023-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Vanda Pharmaceuticals INC. | $55.70 | 2025 | Fanapt |
| Scilex Pharmaceuticals INC. | $44.84 | 2022 | |
| Owp Pharmaceuticals, INC. | $31.25 | 2023-2025 | Subvenite, Lamotrigine |
| Medtronic, INC. | $21.18 | 2022 | |
| Fidia Pharma USA INC. | $19.07 | 2022 | |
| Axsome Therapeutics, INC. | $15.65 | 2022 | |
| Livanova USA, INC. | $13.74 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $12.57 | 2021 | |
| Uswm, LLC | $12.35 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.